Compare BSX & BBVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BSX | BBVA |
|---|---|---|
| Founded | 1979 | 1857 |
| Country | United States | Spain |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 137.8B | 117.0B |
| IPO Year | 1992 | N/A |
| Metric | BSX | BBVA |
|---|---|---|
| Price | $95.58 | $23.18 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 17 | 1 |
| Target Price | ★ $125.88 | N/A |
| AVG Volume (30 Days) | ★ 9.5M | 1.2M |
| Earning Date | 02-04-2026 | 01-29-2026 |
| Dividend Yield | N/A | ★ 2.90% |
| EPS Growth | ★ 54.68 | 7.95 |
| EPS | 1.87 | ★ 2.04 |
| Revenue | $19,349,000,000.00 | ★ $37,116,038,958.00 |
| Revenue This Year | $21.05 | $17.82 |
| Revenue Next Year | $11.44 | $4.98 |
| P/E Ratio | $51.37 | ★ $11.29 |
| Revenue Growth | ★ 21.61 | 6.03 |
| 52 Week Low | $85.98 | $9.44 |
| 52 Week High | $109.50 | $23.45 |
| Indicator | BSX | BBVA |
|---|---|---|
| Relative Strength Index (RSI) | 46.92 | 67.24 |
| Support Level | $95.55 | $23.10 |
| Resistance Level | $96.48 | $23.45 |
| Average True Range (ATR) | 1.69 | 0.29 |
| MACD | 0.38 | -0.00 |
| Stochastic Oscillator | 77.37 | 83.42 |
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
Despite its Spanish origins, Banco Bilbao Vizcaya Argentaria generates only around one-fourth of its profits in Spain. We expect that on a normalized basis, BBVA's market-leading Mexican bank should contribute half of its earnings, while its Turkish operation should account for another 15%. The balance of BBVA's earnings comes from smaller operations in South America. BBVA is overwhelmingly a retail and commercial bank, with corporate and investment banking forming a minor part of the overall business. BBVA also offers insurance and investment products through its banking networks.